Lisanti Capital Growth’s Veracyte VCYT Stock Holding History

Lisanti Capital Growth’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-112,365	Closed	-$2.67M	–	153
2022 Q4	$2.67M	Buy	+112,365	New	+$2.61M	0.36%	98
2021 Q2	–	Sell	-80,280	Closed	-$4.32M	–	162
2021 Q1	$4.32M	Sell	80,280 -7,820	-9%	-$450K	0.55%	76
2020 Q4	$4.31M	Buy	+88,100	New	+$4.08M	0.6%	74
2020 Q1	–	Sell	-106,272	Closed	-$2.97M	–	149
2019 Q4	$2.97M	Buy	+106,272	New	+$2.75M	0.79%	53
2019 Q3	–	Sell	-129,990	Closed	-$3.71M	–	126
2019 Q2	$3.71M	Buy	129,990 +27,480	+27%	+$686K	1.2%	36
2019 Q1	$2.56M	Buy	+102,510	New	+$1.96M	0.91%	50

Other funds holding VCYT

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Lisanti Capital Growth's VCYT Position: Q1 2023 in Review

Lisanti Capital Growth sold out of Veracyte (VCYT) in Q1 2023, closing a stake of 112,365 shares — an estimated $2.67M sold.

Lisanti Capital Growth first reported a position in VCYT in Q1 2019 and held it in 6 quarters. The position peaked at $4.32M in Q1 2021. 232 funds tracked by Wall St. Rank hold VCYT as of Q1 2023.

Lisanti Capital Growth reported no remaining Veracyte position as of Q1 2023 after selling out during the quarter.
Lisanti Capital Growth sold 112,365 Veracyte shares in Q1 2023, an estimated $2.67M.
Lisanti Capital Growth first reported a position in Veracyte in Q1 2019 and held it in 6 quarters.
Lisanti Capital Growth's Veracyte position peaked at $4.32M in Q1 2021.
232 funds tracked by Wall St. Rank held Veracyte as of Q1 2023.

Based on Lisanti Capital Growth's 13F filing for Q1 2023, filed 8 May 2023.